SCHEMBL10693751

SCHEMBL10693751

Cc1nc2c3cccc(Cl)c3ccn2c1CO

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 2/20 0.44
ATP4B P51164 2/20 0.44
MAPT P10636 2/20 0.37
HCRTR1 O43613 1/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2A6 P11509 2/20 0.36
KLKB1 P03952 1/20 0.34
MAP4K1 Q92918 1/20 0.34
NOTUM Q6P988 1/20 0.33
ADRA2A P08913 1/20 0.33
KMT2A Q03164 2/20 0.33
TAAR1 Q96RJ0 1/20 0.33
CYP3A4 P08684 1/20 0.32
CD38 P28907 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10687438 0.84 MAPK1 (0.39) MAPTHCRTR1TP53ALOX15MAPK1
SCHEMBL10691237 0.84 SMN1; SMN2 (0.36) ATP4AATP4BMAPTHCRTR1TP53
SCHEMBL10690375 0.84 CYP1A2 (0.34) ATP4AATP4BMAPTHCRTR1TP53
SCHEMBL10694506 0.84 ATP4A (0.48) ATP4AATP4BMAPTHCRTR1TP53
SCHEMBL10693490 0.84 RAB9A (0.36) MAPTHCRTR1TP53ALOX15MAPK1
SCHEMBL10693410 0.83 HCRTR1 (0.39) MAPTHCRTR1TP53ALOX15MAPK1
Iodide SCHEMBL10692587 0.83 CYP1A2 (0.33) ATP4AATP4BMAPTHCRTR1TP53
SCHEMBL10689158 0.82 MAPT (0.34) ATP4AATP4BMAPTHCRTR1TP53
SCHEMBL10688978 0.82 SMN1; SMN2 (0.34) MAPTHCRTR1TP53ALOX15MAPK1
SCHEMBL10692769 0.82 MAPK1 (0.39) ATP4AATP4BMAPTHCRTR1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4738967-A Imidazoisoquinoline compounds useful as anti-ulcerative agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-04-19 US disclosed
US-4686227-A Imidazoisoquinoline compounds useful as anti-ulcerative agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-08-11 US disclosed
EP-0165545-A2 Imidazoisoquinoline compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-12-27 EP disclosed